Monday, September 10, 2018
Researchers from the Australia-based Baker Heart and Diabetes Institute have developed a new blood test that can help to quickly and easily detect the risk of a secondary heart attack.
Led by the university’s metabolomics head Peter Meikle, the research team has identified plasma lipid biomarkers in the blood that improve upon traditional risk factors in whether a person is at risk of heart disease and stroke.
Meikle said: “The test was developed after a study looked at 10,000 samples to find the biomarkers that will determine whether a person is at risk of having another heart attack.
It is patented under (US20160131667) LIPID BIOMARKERS FOR STABLE AND UNSTABLE HEART DISEASE
“We hope to identify those individuals who are at greatest risk of a second heart attack so that they can be closely monitored and treated accordingly.
“While there are thousands of lipids in the blood, our challenge is to identify which ones best predict disease outcomes.”
So far, a prototype of this test has been trialled in America, but it offers only limited information based on two lipid markers. It is currently unavailable in Australia.
For the cialis in symptoms of prostatitis can disappear temporally, but these treatments can not cure prostatitis, if prostatitis left untreated, more serious condition maybe caused such as male infertility. More the secretion of nitric oxide – more is the circulation of blood. cialis india pharmacy All these come with virtually nil side effects. online viagra mastercard Finally, Theodore Creighton and Gary Jones (2001) point out that few programs cialis properien https://unica-web.com/PATRONAGE/patronage-form-%28en%29.doc currently look beyond grade-point average when recruiting employees into programs.
Under a broader personalised precision health programme, the researchers propose to trial the new blood test in Australia over the next two to three years. Ultimately, a general physician can request this test on patients to better diagnose their risk of developing heart disease.
It is a simple blood test that can be done in out of hospital pathology laboratories that already contain the necessary equipment.
Meikle added: “Our test will use up to ten lipid markers to better diagnose heart disease. It’s a challenging, yet very exciting time. We effectively have the information and are in the process of refining the technology.
“Once the protocols for a diagnostic heart disease blood test are in place; it will be possible to add additional markers for the test to also be used in predicting diabetes and potentially Alzheimer’s disease as well.
“The test will reclassify a patient’s risk of heart attack and stroke. It will better identify who within the ‘intermediate’ risk category are in fact, at higher risk, and help guide physicians in the appropriate treatment of patients.”
Key Facts
News Category Other Product News
Company Baker Heart and Diabetes Institute
Country Australia